There is an urgent need for rapid and coordinated investigation of new candidate drugs during pandemics.
EU-SolidAct is a new Adaptive Platform Trial developed to evaluate drug interventions in hospitalized patients with Covid-19 and to facilitate a joint European response to future pandemics.
The first patients were recruited in June with the opening of the control and Baricitinib arms.
https://ecrin.org/news/eu-solidact-pan-european-platform-pandemic-research-and-preparedness
for articles/videos/studies
Healthcare professionals who wish to be part of a unique network, providing access to up-to-date, accurate and validated information about clinical research.
Investigators and study staff who wish to be part of a unique network, in order to stay abreast of clinical trials taking place in Luxembourg and who are willing to further develop their competencies.
